Sino Biopharmaceutical | 1177 - Assets

Stock Price
6.39
Daily Change
0 0%
Monthly
-1.99%
Yearly
85.76%
Q1 Forecast
6.38

Sino Biopharmaceutical reported CNY74.89B in Assets for its fiscal semester ending in June of 2025.





Assets Change Date
Akebia Therapeutics USD 364.15M 18.56M Sep/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Avita Medical AUD 58.13M 21.58M Jun/2025
Cspc Pharmaceutical CNY 46B 1.61B Jun/2025
Dianthus Therapeutics USD 577.44M 251.37M Sep/2025
Ionis Pharmaceuticals USD 3.03B 47.96M Sep/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Jiangsu Hengrui CNY 68.33B 5.43B Sep/2025
Moderna USD 12.34B 203M Dec/2025
Organon & Co USD 13.55B 52M Sep/2025
Revvity USD 12.17B 29.46M Dec/2025
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Viatris USD 37.92B 491.1M Sep/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025